JANETTE STALLINGS: Open Payments
NPI 1871092353 · BELLEVUE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 83 payments from 13 companies in 2025. Trend: 2023 $1,648 · 2024 $1,862 · 2025 $1,574
Food & beverage: $1,574
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $302 |
| Vanda Pharmaceuticals Inc. | 12 | $243 |
| Supernus Pharmaceuticals, Inc. | 9 | $210 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $135 |
| Axsome Therapeutics, Inc. | 5 | $101 |
| ABBVIE INC. | 5 | $94 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Neos Therapeutics, LP | 4 | $66 |
| HARMONY BIOSCIENCES LLC | 3 | $54 |
Products named: REXULTI, Qelbree, CAPLYTA, HETLIOZ, TRINTELLIX, Auvelity, VRAYLAR, FANAPT.
Industry payments across NE — which companies pay providers there.
